Experiencing Joy

TMS (Transcranial Magnetic Stimulation) is a novel approach to treat depression. It was invented in 1985. Its use in treatment for depression was discovered in the late 1990s through research and clinician experiences.

TMS was FDA-approved in 2008 as a treatment modality for Depression, based on a large, multicenter, placebo-controlled trial for the treatment of Depression (O’Reardon. Biol Psychiatry, 2007). Presently, almost all major health insurances are approving the treatment option.

Efficacy of TMS is mostly seen in patients suffering from TRD (Treatment Resistant Depression), which makes it a valuable intervention for those patients whose Depression has not improved with multiple antidepressant medication trials. Most people observe an improvement of symptoms by the 2nd or 3rd week of treatment with TMS. Research has consistently shown efficacy of TMS as twice that of medications.

TMS is also used as an off-label treatment for Bipolar Disorder with Depression, Obsessive Compulsive Disorder, PTSD, Auditory Hallucinations associated with Schizophrenia, negative symptoms associated with Schizophrenia, Migraine Headaches, Fibromyalgia, and Tinnitus. Off-label prescribing is a safe, legal, and well-accepted practice in which a physician prescribes a medication that is approved to treat a different condition.